CUE
CUE
NASDAQ · Biotechnology

Cue Biopharma Inc

$27.45
-3.96 (-12.61%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target -42.6% upside
Low Target $10.91
Average Target $15.75
High Target $18.65
Current Price $27.45
Current
$27.45
Target
$15.75
$10.91 $15.75 avg $18.65
Scenario Analysis
Bear Case
$10.91
-60.3%
Low target
Base Case
$15.75
-42.6%
Avg target
Bull Case
$18.65
+-32.1%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$45.50
-39.7% from high
52-Week Low
$4.97
+452.3% from low
Target vs 52W High
$15.75
-65.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%